CLINICAL_TRIALS
trial_result
· 2023-02-13
Clinical Trial Update: A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris [Phase 2]
Summary
Phase 2 study of PRN1008 in adults with pemphigus vulgaris completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Principia Biopharma, a Sanofi Company | Conditions: Pemphigus Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2023-02-13